OCUL — Ocular Therapeutix Cashflow Statement
0.000.00%
Last trade - 00:00- $1.22bn
- $799.45m
- $58.44m
- 54
- 15
- 88
- 51
Annual cashflow statement for Ocular Therapeutix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -86.4 | -156 | -6.55 | -71 | -80.7 |
| Depreciation | |||||
| Non-Cash Items | 8.14 | 98.1 | -58.5 | 7.98 | 14.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.88 | 1.18 | -2.9 | 1.35 | -7.41 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -77.6 | -53.6 | -65.5 | -59.6 | -70.2 |
| Capital Expenditures | -2.24 | -0.841 | -1.19 | -3.71 | -6.09 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -2.24 | -0.841 | -1.19 | -3.71 | -6.09 |
| Financing Cash Flow Items | 0 | — | — | — | -5.18 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 75.3 | 228 | 2.85 | 1.45 | 170 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -4.47 | 174 | -63.9 | -61.9 | 93.5 |